分迪药业研发管线

Programs Schedule (Compounds/Indications) Rights
Category Targets/Modalities Discovery Optimization IND Enabling Phase 1 Phase 2 Phase 3

Oncology

 GSPT1 (Molecular Glue)
FD-001: AML\MM\NHL > > > > >
Fendi Pharma
P53 activator (Molecular Glue)
FD-002: AML\NHL > > > > >
Fendi Pharma
Undisclosed (Molecular Glue)
FD-003: NSCLC > > > > >
Fendi Pharma
HER2-DAC
FD-004:> > > > >
Fendi Pharma
CD33-DAC
FD-005:> > > > >
Fendi Pharma
Non-Oncology Undisclosed (Molecular Glue)
> > > > >
&
Undisclosed (Molecular Glue)
> > > > >
&
Undisclosed (Novel E3 ligases)
> > > > >
&

*DAC: Degrader Antibody Conjugates